Controlled-Release Oxycodone and Naloxone in the Treatment of Chronic Low Back Pain: A Placebo-Controlled, Randomized Study by C Cloutier, J Taliano, W O’Mahony, M Csanadi, G Cohen, I Sutton, D Sinclair, M Awde, S Henein, L Robinson, J Eisenhoffer, PS Piraino, Z Harsanyi, KJ Michalko

Get full text

The Pain and Sleep Questionnaire Three-Item Index (PSQ-3): A Reliable and Valid Measure of The Impact of Pain on Sleep in Chronic Nonmalignant Pain of Various Etiologies by Lindsay E Ayearst, Zoltan Harsanyi, Kenneth J Michalko

Get full text

Once-Daily, Controlled-Release Tramadol and Sustained-Release Diclofenac Relieve Chronic Pain due to Osteoarthritis: A Randomized Controlled Trial by André D Beaulieu, Paul M Peloso, Boulos Haraoui, William Bensen, Glen Thomson, John Wade, Patricia Quigley, John Eisenhoffer, Zoltan Harsanyi, Andrew C Darke

Get full text

Representations of OxyContin in North American Newspapers and Medical Journals by Emma Whelan, Mark Asbridge, Susan Haydt

“…Following the approval of OxyContin (Purdue Pharma, Canada) for medical use, the media began to report the use of OxyContin as a street drug, representing the phenomenon as a social problem. …”
Get full text